毕得医药 (688073.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(毕得医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 282,381,419.24270,169,416.30252,455,900.29245,308,114.79219,851,811.08191,603,814.97177,067,881.79
 营业收入(元) 282,381,419.24270,169,416.30252,455,900.29245,308,114.79219,851,811.08191,603,814.97177,067,881.79
二、营业总成本(元) 244,699,215.29206,432,703.95203,401,460.75201,431,542.99170,288,508.79147,663,384.17141,216,584.11
 营业成本(元) 171,349,682.77167,371,682.22142,431,418.90139,264,048.51124,828,394.69107,383,168.2292,322,109.87
 研发费用(元) 14,367,504.1010,613,089.3316,163,087.8713,365,857.0614,244,300.138,729,733.209,733,638.06
 营业税金及附加(元) 650,484.261,817,091.53319,578.371,547,431.561,266,529.101,056,018.7288,740.53
 销售费用(元) 32,842,805.5529,760,323.8925,934,576.2127,718,571.2323,469,578.1121,627,790.3519,909,478.92
 管理费用(元) 27,327,953.3622,792,752.4721,229,375.5821,081,557.3715,871,125.5217,738,425.5017,228,338.68
 财务费用(元) -1,839,214.75-25,922,235.49-2,676,576.18-1,545,922.74-9,391,418.76-8,871,751.821,934,278.05
  其中:利息费用(元) 575,548.30585,482.89432,571.52393,322.37516,666.48991,087.79262,545.81
  其中:利息收入(元) 6,845,515.457,052,625.067,363,343.867,478,616.02699,386.92151,590.45475,788.13
 资产减值损失(元) -4,628,978.31-1,666,609.54-2,300,165.25688,790.09-929,432.62-2,740,645.44-4,513,853.08
 信用减值损失(元) -815,020.32-1,001,589.79-2,790,710.87-1,763,238.78221,484.16-1,426,958.05-1,473,083.00
三、其他经营收益
 加:公允价值变动收益(元) -1,792,077.90-11,810,475.57-516,592.664,764,325.52-3,399,052.58--
 加:投资收益(元) 1,788,173.831,049,570.4441,576.3714,661.94-209,320.49--
 资产处置收益(元) 32,373.35------
 其他收益(元) 2,090,712.813,972,326.97156,391.023,737,960.635,202,977.991,650,717.57251,482.81
四、营业利润(元) 34,357,387.4154,362,814.9043,644,938.1551,319,071.2050,449,958.7539,848,612.4930,115,844.41
 加:营业外收入(元) 223,886.223,173.3810,343.582,165.1112,417.639,002.9816,736.96
 减:营业外支出(元) 93,290.97194,104.92384,427.311,429.67203.97167.6110.30
五、利润总额(元) 34,487,982.6654,171,883.3643,270,854.4251,319,806.6450,462,172.4139,857,447.8630,132,571.07
 减:所得税费用(元) 5,423,380.407,517,096.196,342,614.233,369,009.5011,618,201.356,109,891.424,704,168.64
六、净利润(元) 29,064,602.2646,654,787.1736,928,240.1947,950,797.1438,843,971.0633,747,556.4425,428,402.43
(一)按经营持续性分类
  持续经营净利润(元) 29,064,602.2646,654,787.1736,928,240.19--33,747,556.4425,428,402.43
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 29,588,307.3146,882,138.9636,928,240.1947,950,797.1438,843,971.0633,747,556.4425,428,402.43
  少数股东损益(元) -523,705.05------
 扣除非经常性损益后的净利润(元) 29,142,908.4952,898,459.1638,966,750.9041,170,535.0737,115,331.47--
七、每股收益
 一、基本每股收益(元) 0.330.350.570.760.790.700.52
 二、稀释每股收益(元) 0.330.350.570.760.790.700.52
八、其他综合收益(元) 10,558,939.88-5,079,833.01-14,098,118.887,284,471.87-9,235,803.64-5,644,985.73-80,104.28
 归属于母公司股东的其他综合收益(元) 10,558,939.88-5,079,833.01-14,098,118.887,284,471.87-9,235,803.64-5,644,985.73-80,104.28
九、综合收益总额(元) 39,623,542.1441,574,954.1622,830,121.3155,235,269.0129,608,167.4228,102,570.7125,348,298.15
 归属于母公司所有者的综合收益总额(元) 40,147,247.1941,802,305.9522,830,121.3155,235,269.0129,608,167.4228,102,570.7125,348,298.15
 归属于少数股东的综合收益总额(元) -523,705.05------
公告日期 2023-10-282023-08-312023-04-202023-04-202022-10-282022-09-152023-04-20
审计意见(境内) 标准无保留意见

前瞻产业研究院